Loading...
Header Logo
Keywords
Last Name
Institution

RICHARD DE LA GARZA

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
DivisionPsychiatry & Behavioral Sciences
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Neuroscience
    DivisionNeuroscience

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pharmacology and Chemical Biology
    DivisionPharmacology


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    F31DA005638     (DE LA GARZA, RICHARD)Apr 1, 1995
    NIH/NIDA
    5HT 1A AND 5HT3 RECEPTOR MODDULATION OF COCAINE BEHAVIOR
    Role: Principal Investigator

    F32DA005857     (DE LA GARZA, RICHARD)Sep 30, 1998
    NIH/NIDA
    DOPAMINE SYSTEM MODULATION BY COCAINE REPLACEMENTS
    Role: Principal Investigator

    R03DA015126     (DE LA GARZA, RICHARD)Sep 30, 2001 - Sep 29, 2004
    NIH/NIDA
    Depression Enhances Vulnerability to Cocaine Relapse
    Role: Principal Investigator

    R21DA023588     (DE LA GARZA, RICHARD)Sep 15, 2007 - Aug 31, 2010
    NIH/NIDA
    Cycloserine Enhancement of Extinction Learning
    Role: Principal Investigator

    R01DA023964     (DE LA GARZA, RICHARD)Aug 1, 2008 - Jul 31, 2012
    NIH/NIDA
    Rivastigmine as a Treatment for Methamphetamine Dependence
    Role: Principal Investigator

    R01DA023624     (DE LA GARZA, RICHARD)Aug 1, 2009 - May 31, 2014
    NIH/NIDA
    Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction
    Role: Principal Investigator

    R01DA027134     (DE LA GARZA, RICHARD)Sep 1, 2009 - May 31, 2013
    NIH/NIDA
    RTI-336 as a Treatment for Methamphetamine Dependence
    Role: Principal Investigator

    RC1DA028387     (DE LA GARZA, RICHARD)Sep 30, 2009 - Aug 31, 2012
    NIH/NIDA
    Modafinil and Escitalopram for Cocaine Addiction
    Role: Principal Investigator

    R21DA030722     (DE LA GARZA, RICHARD)Aug 1, 2011 - Jul 31, 2014
    NIH/NIDA
    Exercise as a Behavioral Treatment for Cocaine Dependence
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. De La Garza R, Shuman SL, Yammine L, Yoon JH, Salas R, Holst M. A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the Effects on Craving After Acute Exposure to E-Cigarettes in the Laboratory. Am J Addict. 2019 May 08. PMID: 31066987.
      View in: PubMed
    2. Curtis K, Stewart CJ, Robinson M, Molfese DL, Gosnell SN, Kosten TR, Petrosino JF, De La Garza R, Salas R. Insular resting state functional connectivity is associated with gut microbiota diversity. Eur J Neurosci. 2018 Dec 16. PMID: 30554441.
      View in: PubMed
    3. Stewart CJ, Auchtung TA, Ajami NJ, Velasquez K, Smith DP, De La Garza R, Salas R, Petrosino JF. Correction: Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study. PeerJ. 2018; 6. PMID: 30148001.
      View in: PubMed
    4. Patel MM, Nielsen DA, Kosten TR, De La Garza R, Newton TF, Verrico CD. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573. PMID: 30126012.
      View in: PubMed
    5. Wang JM, Zhu L, Brown VM, De La Garza R, Newton T, King-Casas B, Chiu PH. In Cocaine Dependence, Neural Prediction Errors During Loss Avoidance Are Increased With Cocaine Deprivation and Predict Drug Use. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Mar; 4(3):291-299. PMID: 30297162.
      View in: PubMed
    6. Yoon JH, Weaver MT, De La Garza R, Suchting R, Nerumalla CS, Omar Y, Brown GS, Haliwa I, Newton TF. Comparison of three measurement models of discounting among individuals with methamphetamine use disorder. Am J Addict. 2018 Jul 19. PMID: 30024076.
      View in: PubMed
    7. Lacourt TE, De La Garza R, Dantzer R. Can cancer-related cognitive impairment be considered in isolation from other cancer-related symptoms? Psychooncology. 2018 10; 27(10):2511-2512. PMID: 29956401.
      View in: PubMed
    8. Stewart CJ, Auchtung TA, Ajami NJ, Velasquez K, Smith DP, De La Garza R, Salas R, Petrosino JF. Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study. PeerJ. 2018; 6:e4693. PMID: 29736335.
      View in: PubMed
    9. Patriquin MA, Hamon SC, Harding MJ, Nielsen EM, Newton TF, De La Garza R, Nielsen DA. Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes. Psychiatr Genet. 2017 10; 27(5):178-186. PMID: 28590957.
      View in: PubMed
    10. Thompson-Lake DGY, De La Garza R, Hajek P. Breath holding endurance: stability over time and relationship with self-assessed persistence. Heliyon. 2017 09; 3(9):e00398. PMID: 28924619.
      View in: PubMed
    11. Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder. J Psychopharmacol. 2017 08; 31(8):989-995. PMID: 28695777.
      View in: PubMed
    12. Yoon JH, De La Garza R, Newton TF, Suchting R, Weaver MT, Brown GS, Omar Y, Haliwa I. A COMPARISON OF MAZUR'S k AND AREA UNDER THE CURVE FOR DESCRIBING STEEP DISCOUNTERS. Psychol Rec. 2017 Sep; 67(3):355-363. PMID: 28970640.
      View in: PubMed
    13. Mahoney JJ, Haile CN, De La Garza R, Thakkar H, Newton TF. Electrocardiographic characteristics in individuals with cocaine use disorder. Am J Addict. 2017 Apr; 26(3):221-227. PMID: 28248441.
      View in: PubMed
    14. Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R. The a-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenet Genomics. 2016 09; 26(9):428-35. PMID: 27379509.
      View in: PubMed
    15. De La Garza R, Yoon JH, Thompson-Lake DG, Haile CN, Eisenhofer JD, Newton TF, Mahoney JJ. Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder. Psychiatry Res. 2016 Nov 30; 245:133-140. PMID: 27541349.
      View in: PubMed
    16. Verrico CD, Haile CN, De La Garza R, Grasing K, Kosten TR, Newton TF. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 07; 19(7). PMID: 27207905.
      View in: PubMed
    17. Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R, Raskind MA, Newton TF. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May; 77(5):e561-5. PMID: 27249080.
      View in: PubMed
    18. Baeza-Loya S, Velasquez KM, Molfese DL, Viswanath H, Curtis KN, Thompson-Lake DG, Baldwin PR, Ellmore TM, De La Garza R, Salas R. Anterior cingulum white matter is altered in tobacco smokers. Am J Addict. 2016 Apr; 25(3):210-4. PMID: 27001211.
      View in: PubMed
    19. Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Newton TF, Kosten TR, Haque A, McDevitt JT. Next Generation Programmable Bio-Nano-Chip System for On-Site Detection in Oral Fluids. J Drug Abuse. 2015 Nov 23; 1(1):1-6. PMID: 26925466.
      View in: PubMed
    20. De La Garza R, Verrico CD, Newton TF, Mahoney JJ, Thompson-Lake DG. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. Int J Neuropsychopharmacol. 2015 Sep 12; 19(3):pyv098. PMID: 26364275.
      View in: PubMed
    21. Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9. PMID: 26239766.
      View in: PubMed
    22. Brewer AJ, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ, Kosten TR, Newton TF, De La Garza R. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304. PMID: 25850966.
      View in: PubMed
    23. Christodoulides N, De La Garza R, Simmons GW, McRae MP, Wong J, Newton TF, Smith R, Mahoney JJ, Hohenstein J, Gomez S, Floriano PN, Talavera H, Sloan DJ, Moody DE, Andrenyak DM, Kosten TR, Haque A, McDevitt JT. Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids. Drug Alcohol Depend. 2015 08 01; 153:306-13. PMID: 26048639.
      View in: PubMed
    24. Viswanath H, Velasquez KM, Thompson-Lake DG, Savjani R, Carter AQ, Eagleman D, Baldwin PR, De La Garza R, Salas R. Alterations in interhemispheric functional and anatomical connectivity are associated with tobacco smoking in humans. Front Hum Neurosci. 2015; 9:116. PMID: 25805986.
      View in: PubMed
    25. De La Garza R, Bubar MJ, Carbone CL, Moeller FG, Newton TF, Anastasio NC, Harper TA, Ware DL, Fuller MA, Holstein GJ, Jayroe JB, Bandak SI, Reiman KZ, Neale AC, Pickford LB, Cunningham KA. Evaluation of the dopamine ß-hydroxylase (DßH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 03; 59:40-48. PMID: 25602710.
      View in: PubMed
    26. Thompson-Lake DG, Cooper KN, Mahoney JJ, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R. Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers. Nicotine Tob Res. 2015 Jul; 17(7):796-802. PMID: 25475087.
      View in: PubMed
    27. Mahoney JJ, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6. PMID: 25424624.
      View in: PubMed
    28. Savjani RR, Velasquez KM, Thompson-Lake DG, Baldwin PR, Eagleman DM, De La Garza R, Salas R. Characterizing white matter changes in cigarette smokers via diffusion tensor imaging. Drug Alcohol Depend. 2014 Dec 01; 145:134-42. PMID: 25457737.
      View in: PubMed
    29. Wesley MJ, Lohrenz T, Koffarnus MN, McClure SM, De La Garza R, Salas R, Thompson-Lake DG, Newton TF, Bickel WK, Montague PR. Choosing Money over Drugs: The Neural Underpinnings of Difficult Choice in Chronic Cocaine Users. J Addict. 2014; 2014:189853. PMID: 25197609.
      View in: PubMed
    30. Kalechstein AD, Mahoney JJ, Verrico CD, De La Garza R. Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology. 2014 Oct; 85:493-8. PMID: 24930359.
      View in: PubMed
    31. Verrico CD, Haile CN, Mahoney JJ, Thompson-Lake DG, Newton TF, De La Garza R. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014 Aug 01; 141:72-8. PMID: 24928479.
      View in: PubMed
    32. Mahoney JJ, De La Garza R, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71. PMID: 24951161.
      View in: PubMed
    33. Yoon JH, Shah RS, Arnoudse NM, De La Garza R. Remote physiological monitoring of acute cocaine exposure. J Med Eng Technol. 2014 Jul; 38(5):244-50. PMID: 24841843.
      View in: PubMed
    34. Verrico CD, Mahoney JJ, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2014 Feb; 17(2):223-33. PMID: 24393456.
      View in: PubMed
    35. De La Garza R, Galloway GP, Newton TF, Mendelson J, Haile CN, Dib E, Hawkins RY, Chen CY, Mahoney JJ, Mojsiak J, Lao G, Anderson A, Kahn R. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:44-52. PMID: 24316175.
      View in: PubMed
    36. Mahoney JJ, Kalechstein AD, Verrico CD, Arnoudse NM, Shapiro BA, De La Garza R. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:137-42. PMID: 24239594.
      View in: PubMed
    37. Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs. 2013 Dec; 22(12):1549-68. PMID: 24033127.
      View in: PubMed
    38. Haile CN, De La Garza R, Mahoney JJ, Newton TF. Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase. Drug Alcohol Depend. 2013 Dec 01; 133(2):759-62. PMID: 23968815.
      View in: PubMed
    39. Ross EL, Yoon JH, Mahoney JJ, Omar Y, Newton TF, De La Garza R. The impact of self-reported life stress on current impulsivity in cocaine dependent adults. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 01; 46:113-9. PMID: 23796525.
      View in: PubMed
    40. Brewer AJ, Mahoney JJ, Nerumalla CS, Newton TF, De La Garza R. The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users. Pharmacol Biochem Behav. 2013 May; 106:132-6. PMID: 23541494.
      View in: PubMed
    41. Haile CN, De La Garza R, Mahoney JJ, Nielsen DA, Kosten TR, Newton TF. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS One. 2012; 7(11):e47702. PMID: 23144826.
      View in: PubMed
    42. Mahoney JJ, Newton TF, Omar Y, Ross EL, De La Garza R. The relationship between lifetime stress and addiction severity in cocaine-dependent participants. Eur Neuropsychopharmacol. 2013 May; 23(5):351-7. PMID: 22748418.
      View in: PubMed
    43. Yoon JH, Newton TF, Haile CN, Bordnick PS, Fintzy RE, Culbertson C, Mahoney JJ, Hawkins RY, Labounty KR, Ross EL, Aziziyeh AI, De La Garza R. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers. Addict Behav. 2013 Feb; 38(2):1518-26. PMID: 22560371.
      View in: PubMed
    44. Newton TF, De La Garza R, Brown G, Kosten TR, Mahoney JJ, Haile CN. Noradrenergic a1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012; 7(2):e30854. PMID: 22319592.
      View in: PubMed
    45. Haile CN, Mahoney JJ, Newton TF, De La Garza R. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther. 2012 May; 134(2):260-77. PMID: 22327234.
      View in: PubMed
    46. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Chang LC, Newton TF. Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2012 Oct; 15(9):1241-9. PMID: 22214752.
      View in: PubMed
    47. De La Garza R, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ, Aziziyeh A. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27; 37(1):141-6. PMID: 22230648.
      View in: PubMed
    48. De la Garza R, Yoon JH. Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 01; 35(8):1827-30. PMID: 21803113.
      View in: PubMed
    49. Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R, Rivera O, Anderson A, Mojsiak J, Elkashef A. A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug Alcohol Depend. 2011 Dec 01; 119(1-2):37-45. PMID: 21696894.
      View in: PubMed
    50. Kalechstein AD, Yoon JH, Croft DE, Jaeggi S, Mahoney JJ, De La Garza R. Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals. Pharmacol Biochem Behav. 2011 Sep; 99(3):423-7. PMID: 21624391.
      View in: PubMed
    51. Tziortzis D, Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2011 Apr; 98(2):196-202. PMID: 21215769.
      View in: PubMed
    52. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Newton TF. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30; 35(2):459-65. PMID: 21122811.
      View in: PubMed
    53. Haile CN, De La Garza R, Newton TF. Methamphetamine Cured my Cocaine Addiction. J Addict Res Ther. 2010 Oct 14; 1(103). PMID: 23066512.
      View in: PubMed
    54. Mahoney JJ, Hawkins RY, De La Garza R, Kalechstein AD, Newton TF. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gend Med. 2010 Oct; 7(5):414-21. PMID: 21056868.
      View in: PubMed
    55. Culbertson C, Nicolas S, Zaharovits I, London ED, De La Garza R, Brody AL, Newton TF. Methamphetamine craving induced in an online virtual reality environment. Pharmacol Biochem Behav. 2010 Oct; 96(4):454-60. PMID: 20643158.
      View in: PubMed
    56. Kalechstein AD, De La Garza R, Newton TF. Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. Am J Addict. 2010 Jul-Aug; 19(4):340-4. PMID: 20653641.
      View in: PubMed
    57. Newton TF, De La Garza R, Grasing K. The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. Psychiatry Res. 2010 Aug 30; 179(1):96-100. PMID: 20493549.
      View in: PubMed
    58. Zorick T, Sevak RJ, Miotto K, Shoptaw S, Swanson AN, Clement C, De La Garza R, Newton TF, London ED. Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. J Exp Pharmacol. 2010; 2:13-8. PMID: 27186086.
      View in: PubMed
    59. De La Garza R, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD, Newton TF. Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. Am J Addict. 2009 Nov-Dec; 18(6):481-7. PMID: 19874169.
      View in: PubMed
    60. De La Garza R, Zorick T, London ED, Newton TF. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):173-80. PMID: 19781865.
      View in: PubMed
    61. De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav. 2009 Nov; 94(1):186-93. PMID: 19698734.
      View in: PubMed
    62. Newton TF, De La Garza R, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict. 2009 Jul-Aug; 18(4):294-300. PMID: 19444733.
      View in: PubMed
    63. Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21(3):254-8. PMID: 19776303.
      View in: PubMed
    64. Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R, Palamar J, Halkitis PN, Mojisak J, Anderson A, Li SH, Elkashef A. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2008 Dec; 11(8):1037-45. PMID: 18664303.
      View in: PubMed
    65. Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. Am J Addict. 2008 Mar-Apr; 17(2):83-98. PMID: 18393050.
      View in: PubMed
    66. Fleury G, De La Garza R, Mahoney JJ, Evans SE, Newton TF. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals. Am J Addict. 2008 Mar-Apr; 17(2):103-10. PMID: 18393052.
      View in: PubMed
    67. Rotheram-Fuller E, De La Garza R, Mahoney JJ, Shoptaw S, Newton TF. Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination. Psychiatry Res. 2007 Aug 30; 152(2-3):205-10. PMID: 17449110.
      View in: PubMed
    68. Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13; 31(3):593-9. PMID: 17270333.
      View in: PubMed
    69. Kalechstein AD, De La Garza R, Mahoney JJ, Fantegrossi WE, Newton TF. MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl). 2007 Jan; 189(4):531-7. PMID: 17082969.
      View in: PubMed
    70. Asnis GM, De La Garza R. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol. 2006 Apr; 40(4):322-35. PMID: 16633105.
      View in: PubMed
    71. Newton TF, De La Garza R, Fong T, Chiang N, Holmes TH, Bloch DA, Anderson A, Elkashef A. A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacol Biochem Behav. 2005 Dec; 82(4):704-11. PMID: 16413604.
      View in: PubMed
    72. Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology. 2006 Jul; 31(7):1537-44. PMID: 16319910.
      View in: PubMed
    73. Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology (Berl). 2005 Nov; 182(3):426-35. PMID: 16163531.
      View in: PubMed
    74. De La Garza R. Wistar Kyoto rats exhibit reduced sucrose pellet reinforcement behavior and intravenous nicotine self-administration. Pharmacol Biochem Behav. 2005 Oct; 82(2):330-7. PMID: 16226802.
      View in: PubMed
    75. Fong TW, De La Garza R, Newton TF. A case report of topiramate in the treatment of nonparaphilic sexual addiction. J Clin Psychopharmacol. 2005 Oct; 25(5):512-4. PMID: 16160641.
      View in: PubMed
    76. Newton TF, Kalechstein AD, De La Garza R, Cutting DJ, Ling W. Apathy predicts hedonic but not craving response to cocaine. Pharmacol Biochem Behav. 2005 Sep; 82(1):236-40. PMID: 16181666.
      View in: PubMed
    77. Newton TF, De La Garza R, Kalechstein AD, Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav. 2005 Sep; 82(1):90-7. PMID: 16112720.
      View in: PubMed
    78. Asnis GM, De La Garza R. Interferon-induced depression: strategies in treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):808-18. PMID: 15907352.
      View in: PubMed
    79. De La Garza R, Asnis GM, Pedrosa E, Stearns C, Migdal AL, Reinus JF, Paladugu R, Vemulapalli S. Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):781-92. PMID: 15927336.
      View in: PubMed
    80. De La Garza R, Asnis GM, Fabrizio KR, Pedrosa E. Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats. Psychopharmacology (Berl). 2005 May; 179(2):356-65. PMID: 15565429.
      View in: PubMed
    81. De La Garza R, Newton TF, Kalechstein AD. Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl). 2005 Mar; 178(2-3):347-50. PMID: 15452684.
      View in: PubMed
    82. De La Garza R, Mahoney JJ. A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res. 2004 Sep 24; 1021(2):209-18. PMID: 15342269.
      View in: PubMed
    83. De La Garza R, Fabrizio KR, Radoi GE, Vlad T, Asnis GM. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav Brain Res. 2004 Feb 04; 149(1):77-85. PMID: 14739012.
      View in: PubMed
    84. De La Garza R, Asnis GM. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus. Brain Res. 2003 Jul 04; 977(1):70-9. PMID: 12788515.
      View in: PubMed
    85. Asnis GM, De La Garza R, Kohn SR, Reinus JF, Henderson M, Shah J. IFN-induced depression: a role for NSAIDs. Psychopharmacol Bull. 2003; 37(3):29-50. PMID: 14608239.
      View in: PubMed
    86. De La Garza R, Jentsch JD, Verrico CD, Roth RH. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. Brain Res. 2002 Dec 20; 958(1):20-7. PMID: 12468026.
      View in: PubMed
    87. Jentsch JD, Olausson P, De La Garza R, Taylor JR. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology. 2002 Feb; 26(2):183-90. PMID: 11790514.
      View in: PubMed
    DE LA GARZA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description